Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 2OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neoplasms 46Multiple Myeloma 45Lymphoma 43Neoplasm Metastasis 40Breast Neoplasms 38Lung Neoplasms 37Prostatic Neoplasms 32Carcinoma, Non-Small-Cell Lung 30Leukemia, Myeloid, Acute 28Colorectal Neoplasms 28Melanoma 27Ovarian Neoplasms 25Hematologic Neoplasms 22Urinary Bladder Neoplasms 21Pancreatic Neoplasms 21Lymphoma, Non-Hodgkin 20Glioma 20Carcinoma, Renal Cell 19Sarcoma 18Triple Negative Breast Neoplasms 15Stomach Neoplasms 15Myelodysplastic Syndromes 15Burkitt Lymphoma 15Neuroblastoma 14Lymphoma, Large B-Cell, Diffuse 13Fallopian Tube Neoplasms 13Ependymoma 13Carcinoma 13Brain Neoplasms 13Thyroid Neoplasms 12

Interventions

plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Neutropenia × 30 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT00967785 2026-05-22

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
20 enrolled

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡